Financials data is unavailable for this security.
View more
SmartText is unavailable
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | 1.13% |
---|---|
Return on equity | 1.27% |
Return on investment | 1.20% |
More ▼
Cash flow in USDView more
In 2022, cash reserves at Psyence Biomedical Ltd fell by 519.60k. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 519.60k for operations while cash used for investing totalled .
Cash flow per share | 0.0839 |
---|---|
Price/Cash flow per share | 2.00 |
Book value per share | -0.3979 |
---|---|
Tangible book value per share | -0.3979 |
More ▼
Balance sheet in USDView more
Current ratio | 0.01 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -2.63%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -- |